Delivery Order SPE2DB22D9143-SPE2DB25FZC67
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,464.07 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, was awarded without set-aside designation. The order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency awarded a $15,031.17 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 21, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois, and represents a continuation of the company's...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $2,226.84 for YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement action under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's existing $499.999 billion Indefinite Delivery Contract with DLA through the...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract employs firm fixed-price pricing and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- This delivery order, valued at $5,567.10, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The award was issued by the Defense Logistics Agency on September 4, 2025, with an ultimate completion date of September 25, 2025. This delivery order operates under a firm fixed-price contract structure with no set-aside designation, allowing DMS Pharmaceutical Group to compete on a...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for one dose vials of YF-VAX vaccine. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.99...
- SPE2DB22D9143Indefinite Delivery Contract
- SPE2DB22D9143-SPE2DB25FZC67Delivery Order
The Defense Logistics Agency awarded a $11,134.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical items supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Department of Defense procurement markets. The company's robust portfolio includes distribution of branded and generic prescription drugs, biologics, vaccines, and medical consumables to military and federal healthcare facilities. This particular delivery order for yellow fever vaccine reflects the company's ongoing role in providing essential immunological products to support military personnel health readiness and medical preparedness initiatives across the Defense Department's healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/3/25 |